Millipore Sigma Vibrant Logo

219465 Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem

A cell-permeable dienone-phenolic triterpene compound that exhibits antioxidant and anti-inflammatory properties.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Tripterin, 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid, Proteasome Inhibitor XIX

Primary Target: 20S proteasome
View Products on Sigmaaldrich.com
219465
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
34157-83-0C₂₉H₃₈O₄

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
219465-10MGCN
재고 정보 검색...
—
현재 재고 없음 현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      		 Plastic ampoule 10 mg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      —
      가격 문의
      		 —
      Description
      OverviewA cell-permeable dienone-phenolic triterpene compound that exhibits antioxidant and anti-inflammatory properties. It suppresses LPS-induced pro-inflammatory cytokines release in macrophages and monocytes (IC50 = 40 nM for IL-1β and IL-1α, 80 nM for IL-6, 110 nM for PGE2, and 210 nM for IL-8 and TNF-α), as well as LPS-induced NF-κB activation (IC50 = 270 nM) and NO production (IC50 = 230 nM) in RAW264.7 cells. Preferentially inhibits chymotrypsin-like activity of 20S proteasome with an IC50 of 2.5 µM. Has also been shown to inhibit lipid peroxidation induced by ADP and Fe2+ in rat liver mitochondria (IC50 = 7 µM). Significantly improves the performance in memory, learning, and psychomotor activity in rats. May be useful to minimize inflammation in Alzheimer′s disease (AD).
      Catalogue Number219465
      Brand Family Calbiochem®
      SynonymsTripterin, 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid, Proteasome Inhibitor XIX
      References
      ReferencesYang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.
      Product Information
      CAS number34157-83-0
      ATP CompetitiveN
      FormRed crystals
      Hill FormulaC₂₉H₃₈O₄
      Chemical formulaC₂₉H₃₈O₄
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Target20S proteasome
      Primary Target IC<sub>50</sub>2.5 µM inhibiting chymotrypsin-like activity of 20S proteasome
      Purity≥95% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      219465-10MGCN 04055977218459

      Documentation

      Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Celastrol, Celastrus scandens - CAS 34157-83-0 - Calbiochem Certificates of Analysis

      TitleLot Number
      219465

      References

      참고문헌 보기
      Yang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-June-2008 RFH
      SynonymsTripterin, 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid, Proteasome Inhibitor XIX
      DescriptionA cell-permeable dienone-phenolic triterpene compound with antioxidant and anti-inflammatory properties. It suppresses LPS-induced release of pro-inflammatory cytokines in macrophages and monocytes (IC50 = 40 nM for IL-1β and IL-1α, 80 nM for IL-6, 110 nM for PEG2, and 210 nM for IL-8 and TNF-α). Also suppresses LPS-induced NF-κB activation (IC50 = 270 nM) and NO production (IC50 = 230 nM) in RAW264.7 cells. Preferentially inhibits chymotrypsin-like activity of 20S proteasome with an IC50 of 2.5 µM. Shown to inhibit lipid peroxidation induced by ADP and Fe2+ in rat liver mitochondria (IC50 = 7 µM). Improves performance in memory, learning, and psychomotor activity in rats. May be useful in minimizing inflammation in Alzheimer's disease animal models.
      FormRed crystals
      Intert gas (Yes/No) Packaged under inert gas
      CAS number34157-83-0
      Chemical formulaC₂₉H₃₈O₄
      Structure formulaStructure formula
      Purity≥95% by TLC
      SolubilityDMSO (5 mg/ml) or Ethanol
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesYang, H., et al. 2006. Cancer Res. 66, 4758.
      Westerheide, S.D., et al. 2004. J. Biol. Chem. 279, 56053.
      Jin, H.Z., et al. 2002. J. Nat. Prod. 65, 89.
      Allison, A.C., et al. 2001. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341.
      He, W., et al. 1998. Bioorg. Med. Chem. Lett. 8, 3659.
      Sassa, H., et al. 1990. Biochem. Biophys. Res. Commun. 172, 890.